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Background: Chronic inflammatory conditions of the biliary tree strongly 
predispose patients to biliary carcinoma. The aim of this study was to evaluate the 
role of interleukin-6 (IL-6) expression during biliary carcinogenesis in 
bilioenterostomized hamsters.   
Materials and Methods: Syrian hamsters were subjected to either a 
choledochoduodenostomy (CD, n=11) or a simple laparotomy (SL, n=10) and 
then received N-nitrosobis(2-oxopropyl)amine (BOP) treatment. The animals 
were sacrificed 20 weeks after surgery and the development of biliary carcinoma, 
the presence and degree of cholangitis, and IL-6 expression on the biliary 
epithelia were examined histologically. 
Results: In the CD group, 8 hamsters (73%) demonstrated persistent cholangitis 
and 6 (55%) of them developed intrahepatic biliary carcinoma, while no hamster 
without cholangitis showed any biliary carcinoma. In the SL group, cholangitis 
was recognized in 4 hamsters (40%) and no development of biliary carcinoma 
was identified. A significantly high incidence of tumor development (p=0.024) 
and a close correlation between the presence of cholangitis and the occurrence of 
biliary carcinoma (p=0.013) were thus evident in the CD group. Moreover, the 
degree of cholangitis was significantly higher in the CD hamsters (p=0.041) and 
an IL-6 over-expression was identified in 5 hamsters that had undergone a CD, 
with a scattered expression on the intra- and extrahepatic biliary epithelia. Despite 
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the fact that the induced biliary carcinomas showed a multicentric occurrence in 
the liver, these tumors originated from within the restricted area where IL-6 was 
expressed. 
Conclusions: A deregulated IL-6 over-expression on the biliary epithelia may 
therefore be involved in inflammation-associated biliary carcinogenesis in 




Chronic inflammatory conditions involving the biliary tree such as 
mechanical irritation by means of cholelithiasis (1, 2), chronic cholangitis with 
hepatolithiasis (3), bile stasis and bacterial infection (4) are considered to be high-
risk conditions for developing biliary carcinoma. Biliary carcinoma also occurs 
long after a biliary-enteric anastomosis (5) or sphincteroplasty (6) for benign 
diseases. Persistent cholangitis enhances biliary carcinogenesis through an 
acceleration of cell kinetic activity of the biliary epithelia in hamsters (7, 8).   
The role of cytokines and growth factors has recently been the focus of a 
lot of attention in the development and progression of tumors. The inflammatory 
cytokine interleukin-6 (IL-6), originally identified as a T cell-derived factor 
which triggers antibody secretion and the final maturation of B cells (9), is a 
multifunctional cytokine produced by a wide variety of cells, including 
macrophages (10), lymphocytes (11), fibroblasts (12) and several carcinoma cells 
(13-17) while also mediating inflammatory reactions and immune-mediated 
processes (18, 19). On the other hand, IL-6 acts as a growth-regulating factor that 
interacts with specific membrane receptors on the tumor cell surface to induce 
proliferation or prolongation of survival of the tumor cells (20). However, 
whether the over-expression of IL-6 per se can promote cancer formation remains 
unknown. 
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This study evaluated the potential role by which over-expression of IL-6 on 
the biliary epithelia may contribute to the development of biliary carcinoma in 
vivo, in association with persistent cholangitis in hamsters that had undergone a 
bilioenterostomy. 
 
Materials and Methods 
 
Animals 
Seven-week-old female Syrian golden hamsters (Shizuoka Laboratory 
Animal Center, Shizuoka, Japan) were used. The animals were housed one per 
cage with sawdust bedding under standard laboratory conditions in the 
Laboratory Animal Center for Biochemical Research at Nagasaki University 
Graduate School of Biomedical Sciences. All experiments were performed 
following the Guidelines for Animal Experimentation of Nagasaki University. 
 
Carcinogenic studies 
After the removal of the gallbladder, a choledochoduodenostomy (CD) was 
performed on 11 hamsters following intraperitoneal administration of sodium 
pentobarbital (50 mg/kg of body weight) (21). The control hamsters underwent a 
simple laparotomy (SL) alone (n=10). All animals were given weekly 
subcutaneous injections of N-nitrosobis(2-oxopropyl)amine (BOP) (Nakarai 
Tesque, Kyoto, Japan) at a dose of 5mg/kg body weight in 0.9% saline. BOP 
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injections were started 4 weeks after surgery and continued for 9 weeks. At 
postoperative week 20, the hamsters were sacrificed and the liver and biliary 
systems were removed en bloc. After fixation in 10% neutral formalin, the 
specimens were cut into 6 blocks and embedded in paraffin. Histological sections 
were stained with hematoxylin and eosin and then examined by a pathologist with 
no knowledge of the study. The number of histologically verified biliary 
carcinomas was counted. Carcinomas were defined as lesions that showed signs 
of disruption of epithelial cell polarity and evidence of an invasive event in 
accordance with the WHO classification of tumors in hamsters (22). 
 
Inflammatory changes 
To evaluate the relationship between cholangitis and biliary carcinogenesis, 
the grade of cholangitis was scored in accordance with the infiltration of 
inflammatory cells as follows: grade 0, no cholangitis; grade 1, mild invasion of 
inflammatory cells around the bile duct; grade 2, severe invasion of inflammatory 
cells around the bile duct; grade 3, abscess formation in the liver (7,8). 
 
Immunohistochemical staining for IL-6 
 Immunohistochemical staining for IL-6 was performed using the indirect 
immunoperoxidase method. Tissue sections embedded in paraffin were dewaxed 
in xylene and treated with microwave and incubated with anti-mouse IL-6 
monoclonal antibodies (DAKO, Tokyo, Japan) after the blocking of endogenous 
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peroxidase. The slides were stained with a biotin-labeled secondary antibody 
(DAKO, Tokyo, Japan) and a peroxidase-labeled avidin-biotin complex with 
DAB was used as a substrate. The grade of the expression of IL-6 was determined 
according to the percentage of positively stained biliary epithelial cells as 
follows; (-): 0%, (+): up to 5%, (++): between 5% and 50%, and (+++): more than 
50%. Positive staining for IL-6 with a grade of either (++) or (+++) was 
considered indicate an over-expression of IL-6. 
 
Statistical analyses 
The incidence of tumor development and the presence of cholangitis were 
statistically analyzed using the chi-square test and Fisher’s exact test.  The Mann–
Whitney’s U-test was used to compare the cholangitis score and the number of 
tumors per animal between the groups. The logistic regression analysis was used 
to clarify the correlation between the presence of cholangitis and the occurrence 




Cholangitis and biliary carcinogenesis 
Cholangitis of any extent was identified in 8 (73%) and 4 (40%) hamsters 
that underwent a CD and SL, respectively (Table 1). In the CD hamsters, a high-
scored cholangitis of grades 2 or 3 was evident and the average cholangitis score 
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was 1.3, which was significantly higher than that of 0.4 in the SL hamsters 
(p=0.041). Biliary carcinoma developed in 6 (55%) hamsters that had undergone 
a CD, with a multicentric occurrence in the liver. On the other hand, no hamster 
that underwent an SL showed any biliary carcinoma. There was a significant 
difference in the incidence of biliary carcinoma between the 2 groups (p=0.024). 
In the CD group, 6 (75%) of the 8 hamsters with cholangitis developed biliary 
carcinoma, while no hamster without cholangitis showed biliary carcinogenesis. 
A significant correlation between the presence of cholangitis and the development 
of biliary carcinoma was thus evident in the CD hamsters (p=0.013).  
 
IL-6 expression and biliary carcinogenesis 
The over-expression of IL-6 on the biliary tree was recognized only in 
hamsters that underwent a CD and was identified as stained granules seen in the 
cytoplasm of the biliary epithelia, where the biliary epithelia showed various 
degrees of hyperplastic changes (Figure 1). The IL-6 expression was seen in both 
the intra- and extrahepatic biliary tree (Table 2). The IL-6 over-expression on the 
intrahepatic bile ducts was recognized in 5 CD hamsters and it was demonstrated 
with a scattered expression in the liver. All of these hamsters were associated 
with persistent cholangitis and developing biliary carcinoma. In addition, the 
average cholangitis score in the CD hamsters with biliary carcinoma was 2.0, 
which was significantly higher than that of 0.4 in the CD hamsters without 
carcinoma (p=0.019). On the other hand, only one CD hamster developed biliary 
9 
carcinoma without showing any evidence of IL-6 expression on the biliary tree. 
Interestingly, all biliary carcinomas originated from within the restricted area 
where IL-6 was expressed despite their multicentric occurrence (Figure 2) and 




Biliary tract malignancies represent diagnostic and therapeutic challenges, 
in part because of their aggressive behavior and a lack of understanding of their 
underlying pathogenetic mechanisms. Chronic inflammation of the biliary tree 
has been implicated in biliary tumorigenesis where chronically inflamed biliary 
epithelia render them increasingly susceptible to biliary carcinoma (1-6). 
However, the carcinogenic mechanism still remains unclear.  
BOP is a potent carcinogen in the biliary tract and pancreas of hamsters 
(23). BOP-induced biliary carcinoma shows a histological resemblance to 
carcinoma in humans (22) and has thus made it possible to observe various early 
stage lesions which are often difficult to observe in humans (21, 24). Moreover, 
BOP induces biliary carcinomas within a relatively short period of time although 
biliary carcinomas develop spontaneously in hamsters long after they undergo a 
bilioenterostomy (8). In this study, 6 (55%) of the 11 hamsters that underwent a 
choledochoduodenostomy followed by BOP-treatment developed intrahepatic 
biliary carcinoma and almost all these hamsters were proven to have moderate to 
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severe cholangitis. Meanwhile, no hamster without cholangitis, including the 
hamsters that had undergone a simple laparotomy, showed any biliary 
carcinogenesis. A significant correlation between the presence of cholangitis and 
the development of biliary carcinoma was thus evident in the CD hamsters. 
Based on our scoring system, cholangitis was noted in 40% and 73% of the SL 
and the CD hamsters with BOP treatment, respectively. BOP induces DNA 
damage of the biliary epithelial cells, which may result in BOP-induced 
chemical cholangitis. The baseline incidence of cholangitis in our model is thus 
40%, although the grade of cholangitis is mild in the SL hamsters. These results 
indicated that complicated inflammatory reactions are induced in the biliary tree 
following a choledochoduodenostomy and enhance biliary carcinogenesis.  
Cytokines are low-molecular weight soluble proteins that transmit signals 
between cells and are involved in several disorders. Several cytokines have 
important role in inflammatory reactions. Cancer is also a complex process in 
which cytokines play an important role. An inflammation-related cytokine, IL-6 
shows pleiotrophic effects with both mitogenic and cytoprotective actions on the 
biliary epithelia (25-28) while increasing in the blood and bile of patients with 
cholangiocarcinoma or in cholangiocarcinoma cells in vitro (29, 30). Yokomuro 
et al., (26) demonstrated that exogenous IL-6 and hepatocyte growth factor 
(HGF) are mitogens that predispose normal human biliary epithelial cells to 
cholangiocarcinoma in vitro and that neoplastic transformation is associated with 
constitutive production of these growth factors with acquisition of IL-6/gp130 
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and HGF/met-based autocrine growth control circuits. In addition, in vitro studies 
have demonstrated that inflammatory cytokines induce DNA damage and inhibit 
DNA repair by a nitric oxide dependent mechanism in cholangiocarcinoma cells 
(31) and even in normal hamster gallbladder epithelial cells (32). In the present 
study, IL-6 was demonstrated to show a scattered expression on the biliary tree 
and was identified only in the CD hamsters with moderate to severe cholangitis. 
Moreover, BOP-induced biliary carcinomas showed a multicentric occurrence 
and yet all these tumors, except for a carcinoma in one CD hamster without IL-6 
expression, originated from within the restricted area where IL-6 was expressed. 
Therefore, the results of this in vivo study suggested that persistent cholangitis 
due to a choledochoduodenostomy induced over-expression of IL-6 on the biliary 
epithelia and, as a consequence, the enhanced IL-6 predisposed non-neoplastic 
biliary epithelial cells to acquire a potential of differentiating into biliary 
carcinoma. BOP-induced biliary carcinomas also expressed IL-6 in this study, 
however, the significance of IL-6 expression on the carcinoma cells is unclear. 
The exogenous administration of IL-6 onto cultured biliary epithelial cells or the 
use of IL-6 null mice will contribute to a better understanding of the mechanisms 
of inflammation-associated biliary carcinogenesis. 
In conclusion, continual irritation of the biliary tree by inflammatory 
stimuli could result in a deregulated IL-6 expression on the biliary epithelia that 
may be involved in the biliary carcinogenesis in hamsters following a 
choledochoduodenostomy. Based on this in vivo tumorigenesis model, by which 
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the understanding of the mechanisms of inflammation-related biliary 
carcinogenesis was enhanced, control of the inflammatory reaction by the 
selective inhibition of the IL-6 pathway may offer an opportunity for the 
prevention of biliary carcinoma formation in several inflammatory 
cholangiopathies, such as primary sclerosing cholangitis, hepatolithiasis, or 
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Figure 1 Immunohistochemical staining for IL-6 in a hamster that had 
undergone a choledochoduodenostomy. IL-6 is expressed clearly in 
the cytoplasm of epithelial cells of the intrahepatic bile duct (400×). 
A marked dilation of the intrahepatic bile duct lined by stratified 
hyperplastic epithelium is seen. 
 
Figure 2 An illustration demonstrating the prevalence of IL-6 expression and 
the development of biliary carcinoma on the liver specimens of a 
hamster that had undergone a choledochoduodenostomy. The open 
circles () indicate the area where the IL-6 expression is identified 
on immunohistochemical examination. The closed boxes (■) indicate 
the area where the development of biliary carcinoma is recognized. 
All biliary carcinomas originate from within the restricted area where 
IL-6 is expressed. 
  
Figure 3 IL-6 expression with immunohistochemical staining on the 
cytoplasm of carcinoma cells in a hamster that had undergone a 
choledochoduodenostomy (×400).  
      
Table 1.  Relation between cholangitis and biliary carcinogenesis in hamsters treated with BOP
No. of No. (%) of hamsters Average of No. (%) of hamsters Total no. of     Total no. of     Incidence of CBA
hamsters with/without cholangitis cholangitis with carcinoma carcinomas carcinomas with/without cholangitis
Group examined with without  score IHBD EHBD  induced /CBA with without 
SL 10 4 (40) 6 (60) 0.4 0 0 0 0 0/4 (0%) 0/6 (0%)
CD 11 8 (73) 3 (27) 1.3 a 6 (55)b 0 30 5.0 6/8 (75%)c 0/3 (0%)
BOP: N-nitrosobis (2-oxopropyl) amine
SL: simple laparotomy, CD: choledochoduodenostomy
IHBD : intrahepatic bile duct, EHBD : extrahepatic bile duct 
CBA : carcinoma-bearing animal
a: Significantly different from SL (p=0.041 )
b: Significantly different from SL (p = 0.024)
c: Significant correlation between the presence of cholangitis and biliary carcinogenesis (p=0.013)
Table 2.  IL-6 expression and biliary carcinogenesis in hamsters treated with BOP following a choledochoduodenostomy
Occurrence of
intrahepatic No. of carcinomas Cholangitis IL-6 expression
Hamsters biliary carcinoma developed score IHBD EHBD
1 no 0 1 - +
2 no 0 0 - -
3 no 0 1 + +
4 no 0 0 - -
5 no 0 0 + ++
6 yes 1 3 ++ ++
7 yes 1 3 - -
8 yes 3 1 +++ +++
9 yes 21 2 +++ +++
10 yes 2 1 ++ ++
11 yes 2 2 ++ +++
BOP: N-nitrosobis(2-oxopropyl)amine
IL-6 expression :  (-); no expression,  (+); up to 5%,  (++);  between 5% and 50%, (+++); more than 50%
IHBD : intrahepatic bile duct
EHBD : extrahepatic bile duct 



